9186
T. Okitsu et al. / Tetrahedron 61 (2005) 9180–9187
general procedure for sequential radical cyclization and
aldol reaction. A solution of enamide 1d (200 mg,
0.48 mmol), Bu3SnH (0.26 mL, 0.96 mmol) and AIBN
(7.7 mg, 0.048 mmol) in benzene (5 mL) was heated at
reflux for 45 min. After cooling, a solution of aldehyde 3a
(0.195 mL, 0.192 mmol) in benzene was added to the
mixture and the resulting mixture was refluxed for 12 h and
allowed to cool to room temperature. According to
Enholm’s procedure for workup, the mixture was concen-
trated under reduced pressure and diluted with Et2O. To the
mixture were added DBU (0.32 mL) followed a solution of
iodine in Et2O until the iodine color persisted. The mixture
was filtered through a pad of silica gel and the filtrate was
concentrated under reduced pressure. The crude material
was chromatographed (hexane/AcOEt 7:1/5:1/3:1) to
give 4a (108 mg, 43%) and 5a (84 mg, 33%). Compound
which was dissolved in THF (1 mL). To the solution was
added a 1 M solution of TBAF in THF (0.3 mL, 0.3 mmol)
at room temperature, and the mixture was stirred for two
days. The mixture was diluted with water, and whole was
extracted with AcOEt, washed successively with water and
brine, dried (MgSO4), and concentrated under reduced
pressure. The residue was chromatographed on silica gel
(hexane/AcOEt 7:1) to give 4b. Compound 4b: IR (CHCl3)
3450, 1660 cmK1; 1H NMR (270 MHz, CDCl3) d 2.63 (1H,
dd, JZ8.5, 5.4 Hz), 2.91 (1H, dd, JZ5.4, 4.0 Hz), 3.51 (1H,
d, JZ14.6 Hz), 3.79 (1H, t, JZ8.5 Hz), 4.26, (1H, d, JZ
6.3 Hz), 4.33 (1H, dd, JZ6.3, 4.0 Hz), 4.47 (1H, br s), 5.19
(1H, d, JZ14.6 Hz), 5.82, (1H, dd, JZ15.8, 8.5 Hz), 6.35
(1H, d, JZ15.8 Hz), 6.60–7.59 (25H, m); 13C NMR
(68 MHz, CDCl3) d 44.7, 45.7, 56.2, 56.3, 67.7, 74.7,
126.6, 126.7, 127.1, 127.3, 127.8, 128.4, 128.6, 128.7,
128.8, 129.0, 129.1, 132.9, 135.8, 136.3, 140.2, 140.7,
144.4, 176.1; HRMS calcd for C39H35NO2 549.2668, found
549.2668. Compound 5b: IR (CHCl3) 3400, 1665 cmK1; 1H
NMR (270 MHz, CDCl3) d 2.88 (1H, dd, JZ5.6, 3.5 Hz),
3.06 (1H, dd, JZ5.6, 4.0 Hz), 3.16 (1H, d, JZ14.9 Hz),
3.42 (1H, br), 4.26 (1H, d, JZ9.2 Hz), 4.33 (1H, dd, JZ9.2,
4.0 Hz), 4.75 (1H, br), 5.02 (1H, d, JZ14.9 Hz), 6.08 (1H,
dd, JZ15.8, 6.3 Hz), 6.64 (1H, d, JZ15.8 Hz), 6.90–7.34
(25H, m, Ph); 13C NMR (68 MHz, CDCl3) d 43.8, 45.9,
57.3, 58.0, 67.5, 71.4, 126.4, 126.5, 127.0, 127.2, 127.5,
127.7, 128.1, 128.4, 128.6, 128.7, 128.9, 129.3, 131.5,
136.6, 141.9, 144.9, 175.5. Anal. Calcd for C39H35NO2: C,
85.21; H, 6.42; N, 2.55. Found: C, 84.99; H, 6.44; N, 2.53.
4a: mp 188–190 8C (hexane/AcOEt). IR(CHCl3) 1660 cmK1
;
1H NMR (270 MHz, CDCl3) d 2.67 (1H, dd, JZ4.9,
3.3 Hz), 2.73 (1H, dd, JZ9.2, 4.9 Hz), 3.42 (1H, d of a pair
of ABq, JZ14.5 Hz), 4.06 (1H, d, JZ6.6 Hz), 4.17 (1H, d,
JZ9.2 Hz), 4.29 (1H, dd, JZ6.6, 3.3 Hz), 4.75 (1H, s), 5.21
(1H, d of a pair of ABq, JZ14.5 Hz), 6.11 (2H, br d, JZ
7.3 Hz), 6.87–7.35 (23H, m); 13C NMR (68 MHz, CDCl3) d
44.0, 45.7, 56.5, 57.9, 67.6, 75.6, 126.3, 126.6, 127.0, 127.4,
127.8, 128.0, 128.1, 128.4, 128.5, 128.6, 128.7, 129.0,
129.2, 135.8, 140.0, 140.2, 140.7, 144.4, 176.4. Anal. Calcd
for C37H33NO2: C, 84.86; H, 6.35; N, 2.67. Found: C, 84.80;
H, 6.49; N, 2.61. Compound 5a: mp 179–180 8C (hexane/
AcOEt). IR (CHCl3) 1665 cmK1 1H NMR (270 MHz,
;
CDCl3) d 2.88 (1H, dd, JZ4.6, 3.0 Hz), 2.89 (1H, d of a pair
of ABq, JZ14.9 Hz), 2.96 (1H, dd, JZ4.6, 3.3 Hz), 4.09
(1H, d, JZ9.9 Hz), 4.24 (1H, dd, JZ9.9, 3.0 Hz), 4.35 (1H,
br s), 4.98 (1H, d of a pair of ABq, JZ14.9 Hz), 5.33 (1H, d,
JZ3.3 Hz), 6.07 (2H, br d, JZ7.3 Hz), 6.83–7.28 (23H, m);
13C NMR (68 MHz, CDCl3) d 43.2, 45.9, 58.2, 59.5, 67.5,
72.1, 126.0, 126.1, 126.4, 126.6, 127.0, 127.3, 127.5, 128.1,
128.2, 128.3, 128.4, 128.5, 128.6, 128.9, 136.5, 141.6,
141.7, 142.5, 145.6, 175.7. Anal. Calcd for C37H33NO2: C,
84.86; H, 6.35; N, 2.67. Found: C, 84.56; H, 6.46; N, 2.60.
4.1.19. (3R*,4R*,5S*)-5-Benzhydryl-1-benzyl-3-[(R*)-1-
hydroxyheptyl]-4-phenylpyrrolidin-2-one, 4c. Following
general procedure, the crude material was obtained from 1d
(200 mg, 0.48 mmol), Bu3SnH (0.26 mL, 0.96 mmol),
AIBN (7.7 mg, 0.048 mmol), and 3c (231 mg, 1.92 mmol)
and. After workup, the crude product was chromatographed
(hexane/AcOEt 7:1/3:1) to give 4c (114 mg, 45%) and 2d
(107 mg, 53%). Compound 4c: IR (CHCl3) 3450,
1660 cmK1 1H NMR (270 MHz, CDCl3) d 0.80–1.38
;
(13H, m), 2.51 (1H, dd, JZ8.6, 5.3 Hz), 2.85 (1H, dd, JZ
5.3, 4.0 Hz), 3.29 (1H, br), 3.49 (1H, d, JZ14.9 Hz), 4.21
(1H, d, JZ6.9 Hz), 4.29 (1H, dd, JZ6.9, 4.0 Hz), 5.12 (1H,
d, JZ14.9 Hz), 6.67–7.33 (20H, m); 13C NMR (68 MHz,
CDCl3) d 14.0, 22.5, 24.5, 29.1, 31.7, 34.6, 45.6, 55.3, 56.8,
67.9, 72.7, 126.7, 127.0, 127.1, 127.3, 127.6, 128.5, 128.7,
128.8, 129.0, 136.0, 140.4, 176.8; HRMS calcd for
C37H41NO2 531.3137, found 531.3109.
4.1.18. (3R*,4R*,5S*)-5-Benzhydryl-1-benzyl-3-[(R*,E)-
1-hydroxy-3-phenylallyl]-4-phenylpyrrolidin-2-one, 4b
and its 3-[(S*,E)-1-hydroxy-3-phenylallyl] isomer, 5b.
Following general procedure, the crude material was
obtained from 1d (200 mg, 0.48 mmol), Bu3SnH (262 mL,
0.96 mmol), AIBN (7.7 mg, 0.048 mmol) and 3b (259 mg,
1.92 mmol). The crude product was chromatographed
(hexane/AcOEt 7:1). The first fraction gave a 2.6:1
inseparable mixture (183 mg) of 4b and 2d on the basis of
intensities of signals, d 5.07 (d, JZ14.9 Hz, one of benzylic
H, 4b) and 5.19 (d, JZ14.9 Hz, 2d), in the 1H NMR
spectrum of the mixture. The yields of 4b and 2d were
calculated to be 54 and 20%, respectively. The second
fraction gave 5b (58 mg, 15%). To obtain analytical sample,
4b was silylated. The mixture of 4b and 2d was dissolved in
DMF (0.5 mL), and TBDPSCl (0.062 mL, 0.24 mmol) and
imidazole (33 mg, 0.48 mmol) were added to the mixture at
room temperature. After being stirred for 3 h, the mixture
was diluted with water, and the whole was extracted with
AcOEt. The organic phase was washed successively with
water and brine, dried (MgSO4), and concentrated under
reduced pressure. The residue was chromatographed on
silica gel (hexane/AcOEt 7:1/3:1) to give silylated 4b,
4.1.20. (3R*,4R*,5S*)-5-Benzhydryl-1-benzyl-3-[(R*)-
cyclohexyl(hydroxy)methyl]-4-phenylpyrrolidin-2-one,
4d. Following general procedure, the reaction was carried
out by using 1d (200 mg, 0.48 mmol), Bu3SnH (0.26 mL,
0.96 mmol), ACN (12 mg, 0.048 mmol) and 3d (0.24 mL,
1.9 mmol) in toluene (5 mL). The crude product was
chromatographed (hexane/AcOEt 7:1/3:1) to give 4d
(49.9 mg, 20%) and 2d (150 mg, 75%). Compound 4d: mp
1
144–145 8C (hexane). IR (CHCl3) 3450, 1660 cmK1; H
NMR (270 MHz, CDCl3) d 0.66–1.77 (11H, m), 2.63 (1H,
dd, JZ9.2, 5.6 Hz), 2.87 (1H, dd, JZ5.6, 4.3 Hz), 2.98 (1H,
d, JZ9.2 Hz), 3.46 (1H, d, JZ14.9 Hz), 4.25 (1H, JZ
6.6 Hz), 4.31 (1H, dd, JZ6.6, 4.3 Hz), 5.13 (1H, d, JZ
14.9 Hz), 6.68–7.32 (20H, m); 13C NMR (68 MHz, CDCl3)
d 24.9, 25.7, 26.2, 30.0, 40.0, 45.2, 45.5, 52.6, 56.3, 67.8,